Stock Analiz

Agape ATP Corp ATPC

Medical/Nursing Services · data as of November 13, 2026

$1.27Market cap $1M
Open the interactive analysis →

Agape ATP Corp (ATPC) is a healthcare company listed in the US with a market value of about $1M. In the twelve months to June 30, 2026 it had revenue of $1M and net income of -$1M, a net margin of -100.2%.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of -15% a year, a 5-year average ROIC of -55%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 69% below the current price.

About Agape ATP

Agape ATP is listed in the US and classified in medical/nursing services. Revenue went from $487005 in 2018 to $2M in 2025, growth of about 17.7% a year. It was profitable in 1 of the last 9 years in our data. Its share count rose by 812% over three years (dilution for shareholders).

Score: 0.8 / 5

Value0/5
Future growth2/5
Track record0/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • Profit margin improving
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S1.1
P/B0.1
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield—
Shareholder yield0.0%
Intrinsic value vs. price−69%

Growth and quality

Revenue growth (1 yr)15.2%
Revenue growth (5 yrs, per year)-15.1%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-164.5%
ROIC (5-yr avg.)-55.4%
Profitable years (of last 10)1
Years paying a dividend—

Financials, last 9 years

Fiscal yearTTM202520242023202220212020201920182017
Revenue$1M$2M$1M$1M$2M$1M$3M$1M$487005—
Net income-$1M-$2M-$2M-$2M-$2M-$3M$354766-$716127-$130274-$75362
Free cash flow—————-$849801-$562685———
EPS (diluted)$-1.15$-2.85$-31.74$-27.50$-20.00$-10.00$0.00$0.00$0.00$0.00
Net margin-100.2%-149.6%-186.8%-146.9%-90.9%-248.2%10.3%-55.5%-26.8%—
ROIC—-11.4%-94.2%-35.9%-94.2%-41.3%-1.7%-7.3%-3.6%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Agape ATP stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 69% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Agape ATP pay a dividend?

Not currently.

Is Agape ATP a good stock to buy?

We do not give buy or sell advice. Agape ATP scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.